SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001123292-23-000027
Filing Date
2023-02-14
Accepted
2023-02-14 14:06:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 hookipa13ga.htm SC 13G/A 69159
2 image2.jpg GRAPHIC 40730
3 image3.jpg GRAPHIC 32519
  Complete submission text file 0001123292-23-000027.txt   171601
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filed by) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Subject) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90985 | Film No.: 23626887
SIC: 2834 Pharmaceutical Preparations